Blood sugar levels improve when adults with type 1 diabetes use modern insulin pumps. These are the findings of a study conducted at the University of Gothenburg. Patients are also overwhelmingly ...
Cipla, a global name in inhalation therapies, has announced the launch of Afrezza, the world’s only rapid-acting inhaled insulin, in India. The drug is approved for adults with type 1 and type 2 ...
Arecor said the twiist's technology to measure each microdose—born out of inventor Dean Kamen's DEKA Research & Development—makes it ideal to deliver its ultra-concentrated insulin. (Sequel Med Tech) ...
TUCSON, Ariz. (KGUN) — Diabetics have many options nowadays for their treatment plans. Afrezza is FDA-approved for adults with type 1 or type 2 diabetes as a fast-acting, mealtime insulin, but it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results